Search
Now showing items 1-10 of 19
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group
Ruecker, Frank G. et al. (2019)
Wissenschaftlicher Artikel
IGF1R as druggable target mediating PI3K-delta inhibitor resistance in a murine model of chronic lymphocytic leukemia
Scheffold, Annika et al. (2019)
Wissenschaftlicher Artikel
Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML
Jakobsen, Janus S. et al. (2019)
Wissenschaftlicher Artikel
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation
Cocciardi, Sibylle et al. (2019)
Wissenschaftlicher Artikel
Therapeutic drug monitoring of mycophenolic acid
Eichner, Kajal Kiran (2019)
Dissertation
Clinical utility of a protein-based oncopanel in patients with end-stage head and neck cancer
Doescher, Johannes et al. (2019)
Wissenschaftlicher Artikel
Health-related quality of life and neurocognitive functioning with lomustine-temozolomide versus temozolomide in patients with newly diagnosed, MGMT-methylated glioblastoma (CeTeG/NOA-09): a randomised, multicentre, open-label, phase 3 trial
Weller, Johannes et al. (2019)
Wissenschaftlicher Artikel
Genotyping of circulating tumor DNA in cholangiocarcinoma reveals diagnostic and prognostic information
Ettrich, Thomas J. et al. (2019)
Wissenschaftlicher Artikel
Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations
Jutzi, Jonas Samuel et al. (2019)
Wissenschaftlicher Artikel
Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
Tausch, Eugen et al. (2019)
Wissenschaftlicher Artikel